Antihemophilic Factor (Recombinant [Pegylated]) and Carbidopa
Determining the interaction of Antihemophilic Factor (Recombinant [Pegylated]) and Carbidopa and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Hemofil-M, Koate-DVI, Monoclate-P, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Jivi, Obizur
Synonyms: Antihemophilic factor (human), Antihemophilic Factor (Human)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Antihemophilic Factor (Recombinant [Pegylated])-Carbidopa and levodopa
- Antihemophilic Factor (Recombinant [Pegylated])-Carbidopa and levodopa enteral
- Antihemophilic Factor (Recombinant [Pegylated])-Carbidopa and Levodopa Enteral Suspension
- Antihemophilic Factor (Recombinant [Pegylated])-Carbidopa and Levodopa Extended-Release Capsules
- Antihemophilic Factor (Recombinant [Pegylated])-Carbidopa and Levodopa Extended-Release Tablets
- Antihemophilic Factor (Recombinant [Pegylated])-Carbidopa and Levodopa ODT
- Carbidopa-Antihemophilic Factor (Recombinant [Pegylated]) Injection
- Carbidopa-Antihemophilic Factor (Recombinant [Porcine Sequence])
- Carbidopa-Antihemophilic Factor (Recombinant) (Advate)
- Carbidopa-Antihemophilic Factor (Recombinant) (Afstyla)
- Carbidopa-Antihemophilic Factor (Recombinant) (Helixate FS and Kogenate FS)
- Carbidopa-Antihemophilic Factor (Recombinant) (Kovaltry and Novoeight)